Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Diatide(DITI) -- Ignore unavailable to you. Want to Upgrade?

To: James Baker who wrote (330)	9/17/1998 2:50:00 PM
From: Proton	Read Replies (2) \| Respond to of 344

Re: If there is an approval in the forest... Well, Accutect got its marketing approval. It's interesting to note that DITI rose strongly (over 10%) the day before the press release. It's good to see this company is as trustworthy as ever (there was not even a "by the way" on the patent issue). :-( On a happier note, marketing is scheduled to begin in three weeks. Does anyone know the details of the royalty agreement. There's was another $2 megadollar milestone payment, so the 3Q results should look good. P.